Company Filing History:
Years Active: 2016-2018
Title: Mathew Finniss: Innovator in Pharmaceutical Delivery Systems
Introduction
Mathew Finniss is a notable inventor based in Sussex, Canada, recognized for his contributions to the field of pharmaceutical delivery systems. With a focus on innovative solutions, he has developed technologies that enhance the efficacy of drug delivery.
Latest Patents
Mathew Finniss holds two patents, including his latest work on "Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents." This patent describes asymmetric bifunctional silyl (ABS) monomers that comprise covalently linked pharmaceutical, chemical, and biological agents. These agents can be covalently bound via the silyl group to delivery vehicles, facilitating targeted delivery to specific areas. The patent also details delivery vehicles containing ABS monomers, which can modify the properties of the agents and vehicles, thereby enhancing solubility, stability, hydrophobicity, and targeting.
Career Highlights
Mathew Finniss is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in pharmaceutical sciences. His work has significantly impacted the development of new drug delivery methods.
Collaborations
Mathew collaborates with esteemed colleagues, including Joseph Desimone and Mary E Napier, who contribute to his research endeavors and innovations in the field.
Conclusion
Mathew Finniss is a pioneering inventor whose work in pharmaceutical delivery systems is shaping the future of drug administration. His innovative patents and collaborations highlight his commitment to advancing medical science.